Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
*-- Lithium Americas (Argentina) Corp. Brief: Q1 Loss per share -Basic US$(0.06 )
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
*-- Lithium Americas (Argentina) Corp. Brief: Q1 Loss per share -Basic US$(0.06 )
May 13, 2024 2:44 PM
Previous page:
Sunoco Prices $1.5 Billion Debt Offering
Next page:
Chevron arm launches $500 million fund to invest in low carbon technologies
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
Sunoco Prices $1.5 Billion Debt Offering
Apr 16, 2024
05:54 PM EDT, 04/16/2024 (MT Newswires) -- Sunoco ( SUN ) said late Tuesday it priced a $1.50 billion private offering of senior notes in two tranches at 100% of face value. The offering comprises $750 million of 7% notes due 2029 and $750 million of 7.25% notes due 2032. The company expects the offering to close April 30 and...
Chevron arm launches $500 million fund to invest in low carbon technologies
Apr 16, 2024
April 16 (Reuters) - Chevron's ( CVX ) venture capital arm launched on Tuesday its third fund to invest in renewable energy technologies with a $500 million commitment, as oil majors look to diversify their business in the face of pressure to reduce their emissions. Like the previous two funds, the Future Energy Fund III will focus on innovations in...
Olympics-Team Canada goes for cool factor in Paris Games kit
Apr 16, 2024
TORONTO, April 16 (Reuters) - Team Canada unveiled the kit athletes will wear at this year's Paris Olympics on Tuesday, a high-tech design focusing on thermal comfort while paying homage to the country's indigenous heritage. In designing their first Summer Games collection, Lululemon said it leaned heavily on product testing and feedback from 19 Canadian Olympic and Paralympic athletes across...
Amgen Plans for Phase 3 Trial of Tezepelumab for Lung Disease
Apr 16, 2024
05:56 PM EDT, 04/16/2024 (MT Newswires) -- Amgen ( AMGN ) said late Tuesday it is planning for the phase 3 trial of tezepelumab in chronic obstructive pulmonary disease, encouraged by the results of phase 2a proof-of-concept study. The company said the phase 2a study investigated tezepelumab in moderate to very severe COPD patients. Overall, tezepelumab numerically reduced the annualized...
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2026 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP